April 1, 2017EuroIntervention135 citations
View Full PaperPredilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score
Structured PICO
Does the PSP score predict device-oriented cardiac events in patients undergoing everolimus-eluting bioresorbable scaffold implantation?
P
Population
Patients undergoing everolimus-eluting bioresorbable scaffold implantation
I
Intervention
Predilation, sizing and post-dilation (PSP) scoring
O
Outcome
Device-oriented cardiac events (DoCE) at one-year follow-upcomposite
The newly developed PSP score independently predicts device-oriented cardiac events at 1 year following bioresorbable scaffold implantation.
Abstract
At one-year follow-up, the PSP-1 score was an independent predictor of DoCE. External validation and prospective studies are needed to determine the clinical usefulness of this score.